SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.58 |
| Enterprise Value ($M) | 2.22 |
| Book Value ($M) | 1.46 |
| Book Value / Share | 1.21 |
| Price / Book | 2.45 |
| NCAV ($M) | 1.38 |
| NCAV / Share | 1.14 |
| Price / NCAV | 2.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.79 |
| Return on Assets (ROA) | -1.50 |
| Return on Equity (ROE) | -1.92 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.97 |
| Current Ratio | 2.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.08 |
| Assets | 2.16 |
| Liabilities | 0.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Huang Leaf | 5.70 | -87.50 | |
| 13G/A | Gruber Michele | 3.90 | -87.16 | |
| 13D/A | Kaufman Jonathan H | 16.20 | 5.60 | |
| 13D/A | Chancellor Michael B | 16.00 | 0.00 | |
| 13G | Sabby Management, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,906 | 189,180 | 7.88 | |
| 27,225 | 73,264 | 37.16 | |
| 31,252 | 72,809 | 42.92 | |
| 51,855 | 171,119 | 30.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LEXX – Lexaria Bioscience Corp. | LFVN – LifeVantage Corporation |
| LGVN – Longeveron Inc. | LIXT – Lixte Biotechnology Holdings, Inc. |
| LPCN – Lipocine Inc. |
Financial data and stock pages provided by
Fintel.io